Saturday 17 October 2026
Export SINT’s income statement to Excel — free account
SINTX TECHNOLOGIES, INC.
SINT Healthcare Medical Devices
SINTX TECHNOLOGIES, INC.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 million, down 64.7% from fiscal 2024. In the quarter to June 2026, revenue grew 199.3%, EPS grew 17.6%, free cash flow fell 38.6% and total debt fell 6.42%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.74
0.03
−1.69%
Follow SINT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Piotroski F-Score |
2 | 5 | 4 | 4 | 2 | 3 | — | — | — | 4 |
Altman Z-Score |
(45.42) | (45.92) | (27.03) | (25.46) | (14.96) | (7.77) | (37.42) | — | — | 279,646.58 |
P/S ratio |
10.52 | 0.90 | 0.55 | 1.85 | 25.43 | 42.29 | 4.33 | 0.00 | — | 472,387.34 |
Altman Z″-Score (non-manufacturers) |
(105.96) | (105.09) | (60.76) | (58.84) | (33.07) | (16.53) | (85.45) | (67.09) | — | (27.90) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
P/Operating CF |
(4.57) | (2.31) | (0.46) | (1.38) | (6.47) | (12.22) | (1.92) | 0.00 | — | (3,759,837.74) |
Beneish M-Score |
(3.03) | (4.22) | 0.78 | (1.96) | (0.90) | (3.06) | 3.88 | — | — | (4.20) |
P/B ratio |
3.66 | 0.67 | 0.17 | 0.50 | 0.90 | 0.97 | 0.57 | 0.00 | — | 640,193.11 |
Price to Tangible BV |
4.31 | 0.67 | 0.17 | 0.51 | 0.90 | 0.97 | 0.58 | 0.00 | — | 3,815,686.79 |
EV/Sales |
6.47 | (0.33) | (0.70) | (1.82) | 5.84 | 0.28 | 1.76 | (0.41) | — | 472,387.35 |
EV/EBITDA |
0.00 | 0.08 | 0.16 | 0.27 | 0.00 | 0.00 | 0.00 | 0.40 | — | 0.00 |
EV/Operating CF |
(0.77) | 0.11 | 0.13 | 0.28 | (0.35) | (0.02) | (0.19) | 0.56 | — | (1,003,147.80) |
EV/FCF |
(0.78) | 0.10 | 0.13 | 0.24 | (0.26) | (0.02) | (0.19) | 0.59 | — | (923,663.76) |
Quick Ratio |
1.16 | 1.91 | 1.39 | 0.81 | 5.23 | 8.82 | 0.93 | 2.40 | 0.22 | 0.61 |
Current Ratio |
1.51 | 2.28 | 1.90 | 0.89 | 5.47 | 9.58 | 1.97 | 2.95 | 0.44 | 1.14 |
Net Debt/EBITDA |
0.41 | 0.28 | 0.28 | 0.55 | 1.19 | 3.12 | 0.29 | 0.41 | (0.01) | (0.01) |
Debt/Assets |
0.07% | 0.34% | 0.30% | 3.35% | 11.02% | 1.30% | 0.20% | 1.47% | 4.13% | 26.70% |
Debt/Equity |
0.00 | 0.01 | 0.01 | 0.09 | 0.14 | 0.02 | 0.00 | 0.02 | 0.11 | 0.62 |
Asset Turnover |
0.11 | 0.23 | 0.17 | 0.08 | 0.02 | 0.03 | 0.07 | 0.01 | 0.00 | 0.49 |
Operating CF/Net income |
0.50 | 0.78 | 1.70 | 0.62 | 1.09 | 0.55 | 0.86 | 0.41 | 0.50 | 0.34 |
Capex/Depreciation |
0.25 | (0.48) | (0.30) | (1.46) | (5.54) | (0.72) | (0.31) | (0.56) | (0.05) | (0.32) |
Interest Coverage |
(206.17) | (484.38) | (6,679.00) | (666.76) | (424.80) | (4,252.00) | (1,648.50) | (9.45) | (5.93) | (2.56) |
| (500.75%) | (174.07%) | (114.47%) | (144.02%) | (43.30%) | (107.04%) | (110.29%) | (325.87%) | (111.88%) | (165.24%) | |
| (180.59%) | (88.98%) | (53.21%) | (87.68%) | (35.61%) | (83.82%) | (72.60%) | (172.44%) | (45.62%) | (67.74%) | |
ROIC |
0.00% | (2,676.64%) | (152.41%) | 0.00% | (124.55%) | (626.03%) | (120.05%) | (262.66%) | (84.93%) | (63.62%) |
Return on Tangible Assets |
(713.87%) | (318.52%) | (111.18%) | (341.95%) | (57.09%) | (65.90%) | (342.94%) | (473.68%) | 212.89% | (729.07%) |
Average Days of Receivables |
63.82 | 24.78 | 95.18 | 76.69 | 61.44 | 25.19 | 72.05 | 1,010.47 | 0.00 | 38.83 |
Research and Development Expense of Revenue |
450.59% | 180.15% | 331.67% | 413.20% | 971.29% | 809.43% | 492.60% | 3,148.42% | 0.00% | 41.67% |
Selling, General and Administrative Expense of Revenue |
632.51% | 159.72% | 204.00% | 341.19% | 807.10% | 642.26% | 484.47% | 4,211.58% | 0.00% | 109.28% |
Intangible Assets out of Total Assets |
0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.42 | 0.36 |
Share Based Compensation of Revenue |
196.07% | 2.84% | 11.08% | 23.64% | 50.99% | 7.58% | 0.29% | 44.21% | 0.00% | 1.79% |
Graham Net Nets |
(0.09) | (0.38) | (0.73) | (0.99) | 0.67 | 0.91 | 0.04 | 0.00 | — | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Earnings Yield |
(155.32%) | (417.28%) | (524.55%) | (420.87%) | (58.87%) | (126.95%) | (424.97%) | (2,033.41%) | — | (86.67%) |
Free Cash Flow Yield |
(79.00%) | (360.83%) | (1,013.28%) | (406.84%) | (89.41%) | (37.91%) | (218.09%) | 0.00% | — | 0.00% |
Revenue per Share |
0.37 | 3.89 | 140.48 | 1,040.67 | 505.00 | 742.50 | 6,890.00 | 0.00 | 0.00 | 9.86 |
Operating CF per Share |
(3.09) | (11.66) | (754.81) | (6,842.00) | (8,439.17) | (11,390.00) | (64,350.00) | 0.00 | (1.57) | (4.64) |
Capex per Share |
0.06 | (0.90) | (26.79) | (936.00) | (3,000.00) | (450.00) | (1,470.00) | 0.00 | 0.00 | (0.40) |
Free Cash Flow per Share |
(3.03) | (12.56) | (781.60) | (7,778.00) | (11,439.17) | (11,840.00) | (65,820.00) | 0.00 | (1.57) | (5.04) |
Cash per Share |
1.49 | 4.85 | 178.61 | 4,163.33 | 11,894.17 | 31,688.75 | 17,870.00 | 0.00 | 0.18 | 4.48 |
Shareholders Equity per Share |
1.06 | 5.25 | 469.09 | 3,802.67 | 14,329.17 | 32,255.00 | 52,020.00 | 0.00 | 1.83 | 7.28 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.06 | 5.25 | 469.09 | 3,802.67 | 14,329.17 | 32,255.00 | 52,020.00 | 0.00 | 1.83 | 7.28 |
Free Cash Flow |
(8.41) | (9.31) | (14.62) | (11.67) | (13.73) | (9.47) | (6.58) | (9.41) | (4.69) | (7.79) |
Working Capital |
1.92 | 2.54 | 2.63 | (0.87) | 12.28 | 24.71 | 2.00 | 4.64 | (4.60) | 2.00 |
Capital Expenditures |
0.16 | (0.67) | (0.50) | (1.40) | (3.60) | (0.36) | (0.15) | (0.06) | (0.01) | (0.62) |
Net Current Asset Value |
(0.93) | (1.00) | (1.06) | (2.86) | 10.38 | 22.95 | 0.12 | 3.90 | (5.53) | 0.96 |
EV/EBIT |
0.00 | 0.07 | 0.14 | 0.25 | 0.00 | 0.00 | 0.00 | 0.40 | — | 0.00 |
Capex to Sales |
(0.16) | 0.23 | 0.19 | 0.90 | 5.94 | 0.61 | 0.21 | 0.64 | 0.00 | 0.04 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.39 | 1.50 | 0.34 | 0.17 | 0.16 | 1.06 | 2.47 | 0.88 | 0.57 | 2.20 |
Cash ROIC |
(118.82%) | (123.76%) | (120.22%) | (93.51%) | (40.52%) | (18.37%) | (93.93%) | (67.14%) | (71.15%) | (30.95%) |
Accounts Receivable Turnover |
5.44 | 6.55 | 5.19 | 7.26 | 8.48 | 6.71 | 3.45 | 0.13 | 0.00 | 7.12 |
Accounts Payable Turnover |
1.64 | 1.73 | 1.47 | 0.79 | 2.06 | 2.47 | 2.24 | 0.06 | 0.09 | 5.81 |
Inventory Turnover |
0.84 | 1.17 | 1.34 | 0.90 | 2.23 | 4.63 | 6.97 | 0.66 | 0.03 | 0.46 |
Average Days of Payables |
250.32 | 134.57 | 296.10 | 597.77 | 195.91 | 149.07 | 126.52 | 1,961.88 | 6,020.76 | 63.59 |
Days of Inventory on Hand |
540.62 | 225.93 | 413.42 | 391.17 | 246.31 | 76.07 | 70.22 | 338.93 | 406.71 | 697.05 |
Average Receivables |
0.19 | 0.44 | 0.51 | 0.22 | 0.07 | 0.09 | 0.20 | 0.75 | 1.43 | 2.14 |
Average Payables |
0.34 | 0.47 | 0.54 | 0.34 | 0.22 | 0.19 | 0.25 | 1.02 | 1.20 | 0.65 |
Average Inventory |
0.66 | 0.70 | 0.59 | 0.29 | 0.20 | 0.10 | 0.08 | 0.08 | 3.67 | 8.17 |
Average Assets |
9.46 | 12.39 | 15.57 | 18.81 | 26.14 | 19.80 | 10.33 | 13.08 | 20.45 | 31.06 |
Average Common Equity |
3.41 | 6.33 | 7.24 | 11.45 | 21.50 | 15.50 | 6.80 | 6.92 | 8.34 | 12.73 |
Columns are period end dates